Cardiogen® 20mg (Bioregulator)
CAS: N/A
Biopeptides Cardiogen® 20mg (Bioregulator) is a high-purity synthetic short-chain peptide formulation developed for advanced laboratory research in cardiovascular and regenerative biology. Manufactured using Solid-Phase Peptide Synthesis (SPPS) and validated through HPLC, Mass Spectrometry, and UV analysis, it delivers ≥99% purity, molecular accuracy, and batch-to-batch reproducibility. Cardiogen® is widely used by European research institutions for organ-specific cellular signaling, gene expression regulation, and mitochondrial research models.
$145.00
Research Use Only
Premium Cardiovascular Bioregulatory Research Peptide
Cardiogen® 20mg (Bioregulator) is a laboratory-grade synthetic peptide designed for organ-specific and regulatory pathway research related to cardiac and vascular biology.
It consists of short-chain regulatory peptides studied for their interaction with gene expression, cellular differentiation, and peptide-mediated signaling mechanisms.
Supplied as a high-purity research material, Cardiogen® meets the analytical and documentation standards required by European research institutions.
Scientific Overview
Short-chain bioregulatory peptides are increasingly studied for their role in precise control of cellular communication and transcriptional activity.
These peptides allow researchers to investigate regulatory signaling with predictable degradation profiles and high experimental reproducibility.
Cardiogen® has been examined in laboratory models related to cardiovascular tissue signaling and cellular energy regulation.
European research environments value bioregulators for their stability, traceability, and suitability for controlled in-vitro experimentation.
Mechanism of Action (Research Context)
- Modulation of organ-specific cardiovascular cellular signaling pathways
- Regulation of gene transcription and expression profiles
- Support of cellular differentiation and regulatory mechanisms
- Influence on mitochondrial ATP production in controlled models
- Facilitation of enzymatic activation and peptide-mediated signaling
Primary Research Applications
Organ-Specific Cardiovascular Research: Studying regulatory peptide signaling in cardiac and vascular tissue models.
Gene Expression and Transcription Studies: Investigating peptide-mediated modulation of gene regulation pathways.
Bioregulatory Pathway Research: Exploring short-chain peptide control of intracellular regulatory mechanisms.
Protein Expression Analysis: Assessing peptide influence on protein synthesis and molecular communication.
Mitochondrial Metabolic Research: Evaluating cellular energy production and ATP regulation under controlled conditions.
Matrix and Cellular Interaction Models: Analyzing peptide effects on cellular structure and extracellular matrix behavior.
Molecular Composition and Characteristics
- Molecular Type: Synthetic bioregulatory peptide complex
- Composition: Short-chain di- and tripeptide sequences
- Structure: Linear peptide chains
- Dose Format: 20mg research vial
- Stability: High when stored under recommended laboratory conditions
Stability Profile and Storage Guidelines
- Supplied as a lyophilized powder for enhanced stability
- Recommended storage temperature: −20°C
- Protect from moisture, humidity, and prolonged light exposure
- Avoid repeated freeze–thaw cycles
- Reconstituted solutions remain stable for approximately 24–48 hours under refrigeration
Solubility and Reconstitution Options
- Bacteriostatic water
- Sterile saline solutions
- Acidic buffer systems
- Compatible organic analytical solvents
Technical Specifications
product Name
Cardiogen® 20mg (Bioregulator)
cas
N/A
purity
≥99% (HPLC verified)
unit Size
20 mg
form
Lyophilized powder
synthesis
Solid-Phase Peptide Synthesis (SPPS)
analytical
HPLC, Mass Spectrometry, UV Spectrophotometry
molecular Structure
Short-chain synthetic peptide complex
stability
High when stored under recommended laboratory conditions
Analytical Validation and Quality Assurance
- HPLC purity and consistency confirmation
- Mass Spectrometry molecular identity verification
- UV spectrophotometric concentration analysis
- Batch-to-batch reproducibility assessment
- Microbial and contamination screening
Regulatory and Compliance Statement
Cardiogen® 20mg (Bioregulator) is supplied strictly for laboratory research and scientific investigation. It is not approved for human consumption, veterinary use, cosmetic applications, or medical treatment. Certificates of Analysis (COA) and Material Safety Data Sheets (MSDS) are available upon request to support EU research compliance.
Frequently Asked Questions
It is used in laboratory research focusing on cardiovascular cellular signaling, gene expression regulation, and bioregulatory pathway studies.
Currently, Cardiogen® does not have a registered CAS number, but it is analytically validated for research-grade purity and identity.
Store the lyophilized peptide at −20°C, protected from moisture and light. Avoid repeated freeze–thaw cycles.
No. Cardiogen® 20mg is strictly for laboratory research and is not approved for human or animal use.
Yes. Biopeptides supplies Cardiogen® 20mg to research institutions across Europe with full analytical documentation.
Its short-chain peptide composition enables precise modulation of gene expression, mitochondrial activity, and cardiovascular cellular signaling.
Purity is confirmed using HPLC, while molecular identity and concentration are verified through Mass Spectrometry and UV analysis.
The 20mg format supports multiple experiments, reduced handling variability, and consistent results across extended research timelines.